At JADPRO Live 2023 in Orlando, Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP, briefed advanced practitioners on key US Food and Drug Administration approvals from late 2022 to late 2023. Dr. Holle described indications, mechanisms of action, and monitoring and management of side effects of new therapies in solid malignancies.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406317 | PMC |
| http://dx.doi.org/10.6004/jadpro.2024.15.3.3 | DOI Listing |
Publication Analysis
Top Keywords
2022-2023 drug
4
drug updates
4
updates solid
4
solid tumors
4
tumors jadpro
4
jadpro live
4
live 2023
4
2023 orlando
4
orlando lisa
4
lisa holle
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!